Starpharma Holdings Limited

$80$125

Starpharma Holdings Limited is a biopharmaceutical company and is engaged in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and VivaGel. Starpharma is developing VIRALEZE, an antiviral nasal spray for COVID-19 which is complementary to vaccines and other preventative measures such as distancing and PPE.

Report ID:

UMHE21217

Published:

Jan-2022

Pages:

11

Industry:

HeadQuatered Country:

Australia

Geography:

Clear
  Get a Free Sample
SKU: UMHE21217 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Product Portfolio, and Business Headquarter”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Value
3.    Growth Strategy
4.    Key Products & Services Offered
5.    Infographic
6.    SWOT Analysis
7. Company Revenue Split
8.    Key Financials”

Companies Mentioned

“CTI BioPharma
Nektar”